堀場製作所(6856) – 〔Summary〕〔Delayed〕Summary of Consolidated Financial Statements for the Three Months Ended March 31, 2022(Japanese GAAP)

URLをコピーする
URLをコピーしました!

開示日時:2022/05/17 13:00:00

損益

決算期 売上高 営業益 経常益 EPS
2018.12 21,057,000 2,883,900 2,890,700 526.98
2019.12 20,024,100 2,091,600 2,118,600 365.44
2020.12 18,708,000 1,969,400 1,985,800 311.09

※金額の単位は[万円]

株価

前日終値 50日平均 200日平均 実績PER 予想PER
6,510.0 6,965.8 7,331.35 13.89 12.33

※金額の単位は[円]

キャッシュフロー

決算期 フリーCF 営業CF
2018.12 925,800 1,953,600
2019.12 1,370,400 2,663,800
2020.12 1,720,800 3,225,300

※金額の単位は[万円]

▼テキスト箇所の抽出

Summary of Consolidated Financial Statements for the Three Months Ended March 31, 2022(Japanese GAAP)May 13, 2022Company nameHORIBA, Ltd.Listed stock exchanges: TokyoListing code6856URL: https://www.horiba.com/int/RepresentativeAtsushi Horiba, Chairman & Group CEOTEL: (81)75-313-8121ContactYoshihiro Morita, Department Manager, Finance and Accounting Dept.(Figures have been rounded down to the nearest million yen)(1)Consolidated Operating Results(Percentages represent changes from the corresponding in the previous year)Net SalesOperating IncomeOrdinary IncomeNet Income Attributableto Owners of ParentMillions of yen%Millions of yen%Millions of yen%Millions of yen%Three Months Ended 3/31/2255,51014.38,60545.08,74348.65,72146.7Three Months Ended 3/31/2148,5828.05,93652.45,88550.73,90070.5(Note) Comprehensive income:FY2022Q111,077 million yen(16.9%)FY2021Q19,472 million yen(-%)Net Income Attributableto Owners of Parent per ShareNet Income Attributableto Owners of Parent per Share(Diluted)YenYenThree Months Ended 3/31/22135.59134.88Three Months Ended 3/31/2192.4391.98Total AssetsNet AssetsShareholders’Equity RatioMillions of yenMillions of yen%As of 3/31/22382,235211,35055.1As of 12/31/21371,585204,49354.8As of 3/31/22210,546 million yenAs of 12/31/21203,688 million yenDividend per ShareFirstQuarterSecondQuarterThirdQuarterYear EndTotalYenYenYenYenYenFY 12/2021-50.00-100.00150.00FY 12/2022-FY 12/2022 (Forecast)60.00-120.00180.00(Percentages represent changes from the same period in the previous year)Net SalesOperating IncomeOrdinary IncomeNet Income Attributableto Owners of ParentNet Income Attributableto Owners of Parentper ShareMillions of yen%Millions of yen%Millions of yen%Millions of yen%YenFirst Half119,00017.517,00030.116,80028.811,00025.8260.68Full Year260,00015.938,00018.637,50017.025,50019.7604.301.Consolidated Results for the Three Months Ended March 31, 2022 (January 1, 2022 – March 31, 2022)(2)Consolidated Financial Position(Reference) Net assets excluding subscription rights to shares and non-controlling interests:2.Dividend(Note) Changes in the latest dividend forecasts released: Yes3.Consolidated Forecast for the Year Ending December 31, 2022 (January 1, 2022 – December 31, 2022)(Note) Changes in the latest business forecasts released: Yes1HORIBA, Ltd. (Consolidated)①Shares issued (including treasury stock)March 31, 202242,532,752December 31, 202142,532,752②Treasury stockMarch 31, 2022335,502December 31, 2021335,502③Average number of outstanding sharesJan. – Mar., 202242,197,250Jan. – Mar., 202142,197,239Notes(1)Changes in significant subsidiaries during the period(Changes in specified subsidiaries that caused a change in the scope of consolidation): None(2)Application of the accounting method specific to quarterly consolidated financial statements: Yes(3)Changes in accounting policies, accounting estimates and retrospective restatement①Changes in accounting policies associated with revision of accounting standards: Yes②Changes in accounting policies arising from other than the above: None③Changes in accounting estimates: None④Retrospective restatement: None(4)Number of shares outstanding (common stock)Note 1. This consolidated financial report is not subject to quarterly review by certified public accountants or accounting firms.Note 2. Appropriate use of business forecasts and other important informationThe forecasts of dividend amount and business performance contained in this report have been made based on certain future assumptions, outlooks, and plans which are available at the HORIBA Group as of May 13,2022.However, due to risks and various uncertain factors such as future business operation policies, changes in the economic environment in Japan and overseas, fluctuation of currency rates, it is possible that actual performance would vary considerably from the forecasts.2HORIBA, Ltd. (Consolidated)1.Qualitative Information Concerning Consolidated Results(1)Information Concerning Consolidated Operating Results(For details, see page 12-14, “3. Supplemental Information – HORIBA, Ltd. Financial Highlights for the Three MonthsEnded March 31, 2022”)During the three months ended March 31,2022 (the first quarter), HORIBA, Ltd. (“the Company”) and its consolidated subsidiaries (together “the HORIBA Group” or “HORIBA” as a consolidated group) increased sales by 14.3% year-on-year to 55,510 million yen, due to an increase in sales in the Semiconductor segment. Operating income increased by 45.0% to 8,605 million yen, ordinary income by 48.6% to 8,743 million yen and net income attributable to owners of parent (“net income”) by 46.7% to 5,721 million yen.The operating results of each business segment are summarized as follows.(Automotive Segment)Sales of the ECT (Engineering Consultancy & Testing) business and others in Europe increased. As a result, segment sales increased by 12.5% year-on-year to 13,675 million yen and operating income of 133 million yen was recorded (after an operating loss of 424 million yen in the previous year).(Process & Environmental Segment)Mainly due to the decrease in a large project in Asia recorded in the first three months of the previous year, segment sales decreased by 8.3% year-on-year to 4,788 million yen and operating income decreased by 35.1% to 453 million yen.(Medical-Diagnostics Segment)Mainly due to an increase in sales of hematology analyzers, clinical chemistry analyzers and reagents in Asia, segment sales increased by 5.5% year-on-year to 6,650 million yen. On the profit side, operating income decreased by 5.8% to 154 million yen, partly due to an increase in R&D expenses.(Semiconductor Segment)Sales to semiconductor production equipment manufacturers increased significantly, in response to the expansion of semiconductor manufacturers’ capital expenditures driven by an increase in demand for semiconductors. As a result, segment sales increased by 20.5% year-on-year to 22,225 million yen and operating income increased by 36.6% to 7,180 million yen.(Scientific Segment)Sales of Raman spectrometers and optical components increased. As a result, segment sales increased by 26.4% year-on-year to 8,169 million yen and operating income increased by 185.4% to 683 million yen.3HORIBA, Ltd. (Consolidated)Previous Forecasts(As of Feb. 14)Revised Forecasts(As of May. 13)ChangesNet Sales120,000119,000-1,000Operating Income16,00017,000+1,000Ordinary Income15,80016,800+1,000Net Income Attributable to Owners of Parent10,00011,000+1,000Net SalesAmount : Millions of yenOperating IncomeAmount : Millions of yenPreviousForecasts(As of Feb. 14)ReviseForecasts(As of May. 13)ChangesPreviousForecasts(As of Feb. 14)RevisedForecasts(As of May. 13)ChangesAutomotive32,00029,000-3,000Automotive—Process&Environmental11,00011,000-Process&Environmental1,0001,000-Medical-Diagnostics14,00014,000-Medical-Diagnostics—Semiconductor48,00049,000+1,000Semiconductor14,50015,000+500Scientific15,00016,000+1,000Scientific5001,000+500Total120,000119,000-1,000Total16,00017,000+1,000(2) Information Concerning Consolidated Earnings Forecasts for FY2022The consolidated earnings forecasts are summarized as follows.Our assumption for the exchange rate has been changed from 115 yen to 124 yen against the US dollars and 130 yen to 133 yen against the euro.Consolidated forecasts for the first half of FY2022Amount : Millions of yenConsolidated forecasts for the first half of FY2022 by segmentWith regard to consolidated earnings forecasts for the first half of FY2022, after taking into account the recent foreign exchange rate trend, the Company has revised upward sales and operating income forecasts of the Semiconductor segment and the Scientific segment by 1,000 million yen and 500 million yen respectively. On the other hand, sales of the Automotive segment have been revised downward, since a part of the estimated sales for the first half (3,000 million yen) will be shifted into the second half due to a delay in progress of the business. As a result, overall sales and operating income forecasts have been revised to 119,000 million yen and 17,000 million yen respectively. Also forecasts for ordinary income and net income have been revised upward by 1,000 million yen each, due to an increase in operating income.4HORIBA, Ltd. (Consolidated)Previous Forecasts(As of Feb. 14)Revised Forecasts(As of May. 13)ChangesNet Sales250,000260,000+10,000Operating Income35,00038,000+3,000Ordinary Income34,50037,500+3,000Net Income Attributable to Owners of Parent23,00025,500+2,500Net SalesAmount : Millions of yenOperating IncomeAmount : Millions of yenPreviousForecasts(As of Feb. 14)ReviseForecasts(As of May. 13)ChangesPreviousForecasts(As of Feb. 14)RevisedForecasts(As of May. 13)ChangesAutomotive68,00070,000+2,000Automotive1,5001,500-Process&Environmental23,50023,500-Process&Environmental2,0002,000-Medical-Diagnostics28,50028,500-Medical-Diagnostics500500-Semiconductor96,000103,000+7,000Semiconductor29,00031,500+2,500Scientific34,00035,000+1,000Scientific2,0002,500+500Total250,000260,000+10,000Total35,00038,000+3,000Consolidated forecasts of full year FY2022Amount : Millions of yenConsolidated forecasts of full year FY2022 by segmentWith regard to consolidated earnings forecasts for the full fiscal year, after taking into account the recent foreign exchange rate trend, the Company has revised upward sales of the Automotive segment by 2,000 million yen. Forecasts for sales and operating income of the Semiconductor segment have been also revised upward by 7,000 million yen and 2,500 million yen respectively, while those forecasts of the Scientific segment have been revised upward by 1,000 million yen and 500 million yen respectively. As a result, overall sales and operating income forecasts have been revised to 260,000 million yen and 38,000 million yen respectively, and forecasts for ordinary income and net income have been revised upward by 3,000 million yen and 2,500 million yen respectively due to an increase in operating income.5HORIBA, Ltd. (Consolidated)Dividend per Share (Yen)InterimYear-endTotalPrevious Forecasts(As of Feb. 14)50110160Revised Forecasts60120180Actual Resultsfor FY 202150100150Amendments to dividend forecasts for FY2022The Company’s shareholder return policy is to set the total returns to shareholders (the combined amount of dividend payments and share buybacks) at approximately 30% of consolidated net income.Dividend forecasts for FY2022 had been 160 yen per share for the full year (50 yen for the interim and 110 yen for the year-end) since “Summary of Consolidated Financial Statements for the Year Ended December 31, 2021” on February 14, 2022. However, considering the revised consolidated earnings forecasts for FY2022, the Company has amended the forecasts to increase the year-end per-share dividend forecast by 20 yen (10 yen for the interim) to 180 yen (60 yen for the interim and 120 yen for the year-end).Cautionary statement with respect to earnings forecastsThe forecasts of dividend amount and business performance contained in this report have been made based on certain future assumptions, outlooks, and plans which are available at the HORIBA Group as of May 13, 2022. However, due to risks and various uncertain factors such as future business operation policies, changes in the economic environment in Japan and overseas, fluctuation of currency rates, it is possible that actual performance would vary considerably from the forecasts.6HORIBA, Ltd. (Consolidated)Amount : Millions of yenFY2021(As of December 31, 2021)FY2022 First Quarter(As of March 31, 2022)AssetsCurrent Assets:Cash and bank deposits135,023136,113Trade notes and accounts receivable59,877-Notes and accounts receivable – trade,and contract assets-58,103Marketable securities2,0121,102Merchandise and finished goods17,86419,936Work in process16,51320,755Raw materials and supplies18,73621,395Other current assets9,24910,266Allowance for doubtful accounts(1,232)(1,290)Total Current Assets258,044266,384Fixed Assets:Property, Plant and Equipment:Buildings and structures, net45,64847,173Machinery, equipment and vehicles, net12,98613,633Land15,99416,350Construction in progress9,2319,380Other property, plant and equipment, net4,4414,401Total Property, Plant and Equipment88,30290,939Intangibles:Goodwill966905Software1,9681,882Leasehold interests in land607637Other intangibles881898Total Intangibles4,4234,323Investments and Other Non-Current Assets:Investment securities12,48711,782Retirement benefit asset387431Deferred tax assets5,0025,434Other investments and other assets2,9792,982Allowance for doubtful accounts(43)(44)Total Investments and Other Non-Current Assets20,81420,587Total Fixed Assets113,540115,850Total Assets371,585382,2352. Consolidated Financial Statements and Notes(1) Consolidated Balance Sheets7HORIBA, Ltd. (Consolidated)Amount : Millions of yenFY2021(As of December 31, 2021)FY2022 First Quarter(As of March 31, 2022)LiabilitiesCurrent Liabilities:Trade notes and accounts payable29,54632,287Short-term loans payable25,10724,310Accounts payable – other16,40717,869Accrued income taxes7,6324,115Advances received14,308-Contract liabilities-16,675Accrued bonuses to employees1,1372,008Accrued bonuses to directors and corporate auditors-163Reserve for product warranty2,6302,742Other current liabilities5,3685,418Total Current Liabilities102,139105,592Non-Current Liabilities:Corporate bonds30,00030,000Long-term loans payable25,07725,357Deferred tax liabilities1,7311,479Retirement benefit liability2,1072,276Other non-current liabilities6,0366,178Total Non-Current Liabilities64,95365,291Total Liabilities167,092170,884Net AssetsShareholders’ EquityCommon stock12,01112,011Capital surplus18,62418,624Retained earnings166,892168,394Treasury stock(1,323)(1,323)Total Shareholders’ Equity196,204197,706Accumulated Other Comprehensive IncomeNet unrealized holding gains or losses on securities5,6645,175Foreign currency translation adjustments1,8897,734Remeasurements of defined benefit plans(69)(69)Total Accumulated Other Comprehensive Income7,48412,840Subscription Rights to Shares791791Non-Controlling Interests1212Total Net Assets204,493211,350Total Liabilities and Net Assets371,585382,2358HORIBA, Ltd. (Consolidated)Amount : Millions of yenFY2021 First Quarter(Three Months EndedMarch 31, 2021)FY2022 First Quarter(Three Months EndedMarch 31, 2022)Net Sales48,58255,510Cost of Sales28,33231,534Gross Income20,24923,975Selling, General and Administrative Expenses14,31315,369Operating Income5,9368,605Non-Operating IncomeInterest income6056Dividend income21Foreign exchange gains-119Subsidy income4880Other5658Total Non-Operating Income168316Non-Operating ExpensesInterest expenses108123Foreign exchange losses67-Other4354Total Non-Operating Expenses218178Ordinary Income5,8858,743Extraordinary GainGain on sales of fixed assets31Gain on sales of investment securities60Total Extraordinary Gain102Extraordinary LossesLoss on sales of fixed assets00Loss on disposal of fixed assets1914Loss on sale of investment securities-0Total Extraordinary Losses2015Income before Income Taxes5,8758,730Income taxes (current)1,9753,346Income taxes (deferred)0(334)Total Income Taxes1,9763,012Net Income3,8985,718Loss attributable to non-controlling interests(1)(3)Net Income Attributable to Owners of Parent3,9005,721(2) Consolidated Statements of Income and Consolidated Comprehensive Income Statements(Consolidated Statements of Income)9HORIBA, Ltd. (Consolidated)Amount : Millions of yenFY2021 First Quarter(Three Months EndedMarch 31, 2021)FY2022 First Quarter(Three Months EndedMarch 31, 2022)Net Income3,8985,718Other Comprehensive IncomeNet unrealized holding gains or losses on securities730(489)Deferred gains or losses on hedges(6)-Foreign currency translation adjustments4,8435,848Remeasurements of defined benefit plans50Total Other Comprehensive Income5,5735,358Comprehensive Income9,47211,077(Breakdown of comprehensive income)Comprehensive income attributable to owners of parent9,47311,077Comprehensive income attributable to non-controlling interests(0)(0)(Consolidated Statements of Comprehensive Income)10HORIBA, Ltd. (Consolidated)(3) Notes to Consolidated Financial StatementsApplication of special accounting for preparing quarterly consolidated financial statement(Calculation method for tax expenses)The Company and its domestic consolidated subsidiaries calculated income tax expenses by multiplying quarterly income before income taxes by reasonably estimated annual effective tax rate. This tax rate was reasonably estimated after applying the deferred tax accounting to the annual income before income taxes.Change in accounting Policies(Application of Accounting Standard for Revenue Recognition, etc.)The Company has applied the “Accounting Standard for Revenue Recognition” (ASBJ Statement No. 29, March 31,2020; hereinafter “Accounting Standard for Revenue Recognition”), etc. from the beginning of the first quarter of FY 2022. Accordingly, revenue is recognized at the time of transfer of control over promised goods or services to the customer in the amount expected to be received in return for the goods or services.The application of the Accounting Standard for Revenue Recognition, etc. is subject to the transitional treatment provisions in Article 84, but there is no impact on the balance of retained earnings at the beginning of FY 2022.There is no impact on the operating results due to the application of Accounting Standard for Revenue Recognition, etc..Due to the application of the Accounting Standard for Revenue Recognition, etc., “Trade notes and accounts receivable” presented under “Current Assets” in the consolidated balance sheets for the previous fiscal year, is included in “Notes and accounts receivable – trade, and contract assets” instead, and “Advances received” presented under “Current Liabilities” in the consolidated balance sheets for the previous fiscal year, is included in “Contract liabilities” instead from the beginning of the first quarter of FY 2022.In accordance with the transition provisions in Article 89-2 of the Accounting Standard for Revenue Recognition, the Company has not reclassified financial statements for the previous fiscal year by using the new presentation method.(Application of “Accounting Standard for Fair Value Measurement,” etc.)The Company has applied the “Accounting Standard for Fair Value Measurement” (ASBJ Statement No. 30, July 4, 2019 (hereinafter “Accounting Standard for Fair Value Measurement”)), etc. from the beginning of the first quarter of FY 2022.The Company has prospectively applied new accounting policies based on the Accounting Standard for Fair Value Measurement, etc. in accordance with the transition provisions in Article 19 of Accounting Standard for Fair Value Measurement and Article 44-2 of “Accounting Standard for Financial Instruments” (ASBJ Statement No.10, July 4, 2019). There is no impact of these changes on quarterly financial statements.Additional information(Application of tax effect accounting for transition from consolidated taxation system to group tax sharing system)With regard to the transition to group tax sharing system established in the “Act for Partial Amendment of the Income Tax Act, etc.” (Act No. 8 of 2020) and items for which the non-consolidated taxation system has been reviewed in line with the transition to the group tax sharing system, the Company and its domestic consolidated subsidiaries calculated the amounts of deferred tax assets and deferred tax liabilities in accordance with the provisions of the tax act before the amendment based on the treatment of Paragraph 3 of the “Practical Solution on the Treatment of Tax Effect Accounting for the Transition from the Consolidated Taxation System to the Group Tax Sharing System” (ASBJ Practical Issues Tax Force No. 39, March 31, 2020), instead of applying the provision of Paragraph 44 of the “Implementation Guidance on Tax Effect Accounting” (ASBJ Guidance No. 28, February 16, 2018).11HORIBA, Ltd. (Consolidated)3. Supplemental InformationHORIBA, Ltd. Financial Highlights for the Three Months Ended March 31, 20221. Consolidated Financial ResultsAmount : Millions of yen12/2021Results12/2022ResultsChanges12/2021Results12/2022Forecasts1Q (3 Months)1Q (3 Months)AmountRatio1st HalfFull Year1st HalfFull YearNet Sales48,582+6,927+14.3% 101,317 224,314119,000 260,000Operating IncomeOperating Income RatioOrdinary IncomeOrdinary Income RatioNet Income Attributableto Owners of ParentNet Income RatioUS$Euro5,93612.2%5,88512.1%3,9008.0%106.09127.8155,5108,605+2,669+45.0%13,06932,04617,00038,00015.5%+3.3P12.9%14.3%14.3%14.6%8,743+2,857+48.6%13,04732,03816,80037,50015.8%+3.7P12.9%14.3%14.1%14.4%+1,821+46.7%8,74421,31111,00025,5005,72110.3%116.34130.40+2.3P+10.25+2.598.6%9.5%9.2%9.8%107.82129.89109.90129.91- 124.00- 133.002. Consolidated Segment ResultsNet Sales12/2021Results12/2022ResultsChanges12/2021ResultsAutomotive12,15313,675+1,522+12.5%24,92461,24929,00070,0001Q (3 Months)1Q (3 Months)AmountRatio1st HalfFull Year1st HalfFull YearAmount : Millions of yen12/2022ForecastsProcess&EnvironmentalMedical-DiagnosticsSemiconductorScientificTotalOperating IncomeAutomotiveProcess&EnvironmentalMedical-DiagnosticsSemiconductorScientificTotal5,2246,30218,4416,46148,5824,7886,65022,2258,16955,510-436 -8.3%10,04020,21711,00023,500+347+5.5%12,89625,88214,00028,500+3,784+20.5%40,04387,00449,000 103,000+1,708+26.4%13,41229,95816,00035,000+6,927+14.3%101,317 224,314 119,000 260,00012/2021Results12/2022ResultsChanges12/2021Results12/2022Forecasts1Q (3 Months)1Q (3 Months)AmountRatio1st HalfFull Year1st HalfFull Year(424)6991645,2572395,9361334531547,1806838,605+558-(1,187)(13)-245 -35.1%1,1141,9471,000-9 -5.8%326148–1,5002,000500+1,922+36.6%12,35128,00615,00031,500+443+185.4%4641,9571,0002,500+2,669+45.0%13,06932,04617,00038,00012HORIBA, Ltd. (Consolidated)3. Consolidated Segment Sales by Destination12/2021Results12/2022ResultsChanges1Q (3 Months)1Q (3 Months)AmountRatioAmount : Millions of yen12/2021ResultsFull Year12/2022ForecastsFull YearAutomotive12,1534,81013,6754,962Process&EnvironmentalMedical-DiagnosticsSemiconductorJapanAsiaAmericasEuropeJapanAsiaAmericasEuropeJapanAsiaAmericasEuropeJapanAsiaAmericasEuropeJapanAsiaAmericasEuropeJapanAsiaAmericasEuropeTotal+1,522+12.5%+151+3.2%-1,380 -41.2%+378+47.5%+2,373+74.2%-409 -30.0%-436 -87 +39+21+347+13+260-29 +103+199+126+325+652+509+221-8.3%-3.2%+7.5%+3.7%+5.5%+0.9%+19.7%-2.1%+4.9%+9.2%+11.4%+15.2%+51.6%+27.8%+18.1%+3,784+20.5%+1,406+24.1%+2,051+22.0%+6,927+14.3%+1,810+10.6%+1,174+7.1%+1,097+16.3%+2,845+34.7%1,9671,1745,5714,7882,6759575675876,6501,4901,5801,3732,20522,2257,23811,3792,3681,2398,1692,4651,9182,3421,44355,51018,83217,8037,82511,04861,24917,36515,8426,47521,56620,21710,2865,0462,2812,60325,8825,2435,7145,8169,10887,00426,83344,8579,8135,50029,9586,6868,0578,9926,223224,31466,41479,51733,37945,0023,3487963,1985,2242,7621,3675275666,3021,4771,3201,4032,10218,4415,8319,3272,1681,1136,4612,1401,2651,8321,22248,58217,02216,6286,7288,20370,00015,50017,0008,50029,00023,50011,5006,0002,5003,50028,5006,0006,5006,5009,500103,00032,00052,00013,0006,00035,0008,0009,80010,5006,700260,00073,00091,30041,00054,700Scientific+1,708+26.4%13HORIBA, Ltd. (Consolidated)5. Consolidated Financial Results (Quarterly Comparison)12/2021 ResultsAmount : Millions of yen12/20221Q2Q3Q4Q1Q Results2Q Forecasts 2H ForecastsNet SalesOperating Income48,58252,73452,6395,9367,1336,78970,35612,18755,51063,489141,0008,6058,39421,000Operating Income Ratio12.2%13.5%12.9%17.3%15.5%13.2%14.9%Ordinary Income5,8857,1616,82012,1698,7438,05620,700Ordinary Income Ratio12.1%13.6%13.0%17.3%15.8%12.7%14.7%Net Income Attributableto Owners of Parent3,9004,8444,9767,5905,7215,27814,500Net Income Ratio8.0%9.2%9.5%10.8%10.3%8.3%10.3%6. Consolidated Segment Results (Quarterly Comparison)12/2021 ResultsAmount : Millions of yen12/2022Net SalesAutomotiveProcess&EnvironmentalMedical-DiagnosticsSemiconductorScientificTotalOperating IncomeProcess&EnvironmentalMedical-DiagnosticsSemiconductorScientificTotal1Q2Q3Q4Q1Q Results2Q Forecasts 2H Forecasts12,15312,77012,38823,93713,67515,3245,2246,3024,8166,5934,5276,2265,6496,7594,7886,6506,2117,34918,44121,60222,64024,32122,22526,7746,4616,9516,8579,6888,1697,83041,00012,50014,50054,00019,00048,58252,73452,63970,35655,51063,489141,00012/2021 Results12/20221Q2Q3Q1Q Results2Q Forecasts 2H Forecasts6991645,2572395,9364141627,0932247,133(747)180(242)7,3702286,7894Q1,921652638,2841,26512,1871334531547,1806838,605(133)546(154)7,8193168,3941,5001,00050016,5001,50021,000Automotive(424)(763)ContactCorporate Planning and Investor Relations, Corporate Planning Office, Finance and Legal Division, HORIBA, Ltd. 2, Miyanohigashi-cho, Kisshoin, Minami-ku, Kyoto 601-8510, JapanE-mail: ir-info@horiba.com14HORIBA, Ltd. (Consolidated)

この記事が気に入ったら
いいね または フォローしてね!

シェアしたい方はこちらからどうぞ
URLをコピーする
URLをコピーしました!